6.37 USD
↘ 0.02 (0.23%)PRE MARKET (AS OF 07:04 AM EDT)
Aligos Therapeutics, Inc. Common Stock
ALGSNASDAQ • USD
Market: OPEN
Open?$6.46
High?$6.46
Low?$6.39
Prev. Close?$6.40
Volume?123
Avg. Volume?298.7K
VWAP?$6.39
Rel. Volume?0.00x
Bid / Ask
Bid?$6.27 × 100
Ask?$6.33 × 100
Spread?$0.06
Midpoint?$6.30
Valuation & Ratios
Market Cap?39.6M
Shares Out?5.4M
Float?4.6M
Float %?75.5%
P/E Ratio?N/A
P/B Ratio?0.74
EPS?-$3.91
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.90Strong
Quick Ratio?3.90Strong
Cash Ratio?0.86Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?0.74CHEAP▾
P/S?18.12HIGH▾
P/FCF?N/A▾
EV/EBITDA?-0.3CHEAP▾
EV/Sales?9.83HIGH▾
Returns & Efficiency
ROE?-45.2%WEAK▾
ROA?-27.3%WEAK▾
Cash Flow & Enterprise
FCF?$-82940000
Enterprise Value?$21.5M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Employees
82
Market Cap
39.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059